Ipratropium bromide in acute asthma: Small beneficial effects? [5]

Chest

Volumn 115, Issue 5, 1999, Pages 1482-

  Rodrigo, G ^a   Rodrigo, C ^a  

^a Centro de Terapia Intensiva   (Uruguay)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; IPRATROPIUM BROMIDE; SALBUTAMOL;

ASTHMA; CLINICAL PROTOCOL; CLINICAL TRIAL; DRUG EFFECT; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LETTER; META ANALYSIS; METERED DOSE INHALER; NEBULIZATION; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL;

EID: 0032948467     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.115.5.1482     Document Type: Letter

References (4)

1. SF Lanes JE Garrett CE Wentworth III The effect of adding ipratropium bromide to salbutamol in the treatment of acute asthma: a pooled analysis of three trials Chest 114 1998 365 372
2. C Rodrigo G Rodrigo Therapeutic response patterns to high and cumulative doses of salbutamol in acute severe asthma Chest 113 1998 593 598
3. C Rodrigo G Rodrigo Treatment of acute asthma: administration of high doses of salbutamol and ipratropium bromide delivered by metered dose inhaler with a spacer (Volumatic) [abstract] Am J Respir Crit Care Med 153 1996 A60
4. 2-agonists for treating acute childhood and adolescent asthma? A systematic review BMJ 317 1998 971 977